Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00305240
Status:
COMPLETED
Last Update Posted:
2008-02-13
First Post:
2006-03-20
Brief Title:
MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients
Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Organization:
Medtronic Cardiac Rhythm and Heart Failure
Study Overview
Official Title:
Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients MASTER I
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine the usefulness of microvolt T wave alternans MTWA testing of patients that have had a heart attack and have decreased pumping ability of the lower chamber of their heart MTWA testing is a non-invasive test used to detect the likelihood of developing abnormally fast rhythms in the lower chambers of the heart The objective of the study is to prove that if a patient has a negative MTWA test they will be less likely to develop abnormally fast and dangerous rhythms in the lower chambers of the heart The results of the study will help doctors to determine which patients would benefit the most from having an Implantable Cardioverter Defibrillator ICD implanted
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None